15
Participants
Start Date
June 30, 2016
Primary Completion Date
March 31, 2020
Study Completion Date
June 30, 2020
Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)
"Adrenocorticotropic hormone (ACTH) gel, a long-acting formulation of the full sequence ACTH that includes other pro-opiomelanocortin (POMC) peptides, is considered an alternative to corticosteroids in the treatment of relapses (currently FDA approved for this indication).~ACTH (H.P. Acthar®) gel exerts direct anti-inflammatory and immune-modulating effects within the CNS, specifically on infiltrating macrophages and resident microglia as well as protecting mature oligodendrocytes from inflammation-related damage and excitotoxicity. These effects are mediated not only via induction of endogenous corticosteroid production but also via effects on melanocortin receptors."
Weill Cornell Medicine, New York
Collaborators (1)
Mallinckrodt
INDUSTRY
Weill Medical College of Cornell University
OTHER